Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
Psoriatic arthritis (PsA) is a chronic inflammatory disease characterized by skin and joint involvement. The disease may present with various joint pattern involvement, which sometimes may lead to joint destruction and deformity. Early diagnosis and treatment with disease-modifying anti-rheumatic dr...
Guardado en:
Autores principales: | Fusun Gediz, Mehmet Can Ugur, Meltem Turkmen, Senol Kobak |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/141f651f5b3f4b3ab69770712b9362bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders
por: D'Angelo S, et al.
Publicado: (2017) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018) -
Psoriasis to Psoriatic Arthritis: The Application of Proteomics Technologies
por: Fei Qi, et al.
Publicado: (2021) -
AGE-DEPENDENT INDEXES OF IMMUNITY IN THE PATIENTS WITH PSORIATIC ARTHRITIS
por: A. A. Barilo, et al.
Publicado: (2019) -
An unusual presentation of chronic lymphocytic leukemia
por: Dinesh Atwal, et al.
Publicado: (2017)